Caring for patients’ mental health in clinical trials
August 6, 2024 | care, clinical trials, mental health, patients
We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.
Mental health awareness week, just like a lot of other awareness weeks and days, is invaluable in bringing attention to important causes. But we also need to remember that those important causes don’t just subside for the other 51 weeks or 364 days of the year.
Which is exactly why we’re talking about mental health in clinical trials now, a few weeks after mental health awareness week. Because this affects patients all year round. For example, almost 1 in 6 cancer patients experience moderate to severe symptoms of anxiety and over 1 in 10 cancer patients experience moderate to severe depression.1 And in one study, it was found that the depression rate increases further to almost 3 in 5 patients when they experience serious adverse events as a byproduct of their treatment.2
Add onto that the demands of a clinical trial, and it can quickly become too much for some patients to deal with. Chronically unwell patients can find constant clinical interferences and interventions exhausting, and patients can easily become physically and mentally exhausted by travelling to and from their appointments.3
Which can quickly become one of the main reasons for people dropping out of clinical trials. A further study also reported that those who report poorer baseline mental health are also less likely to attend assessments and engage with resources, which can also have a lasting impact on trial engagement and recruitment.4 The truth is, there are probably a number of factors playing out, and of course they’re all interlinked.
Mentally exhausted from travelling = decide to not travel = don’t attend assessments.
It’s certainly not cut and dried though. As is often the case.
And whilst we started this article by talking about how awareness of mental health conditions has certainly increased over the last few years, clinical investigation into related conditions remains fraught with challenges, and it is still common practice to exclude patients with known mental health conditions in clinical trials. We know that those with depression tend to be less adherent to treatment, which can have an effect on treatment response. But there is also a need to be fully inclusive.
So, what can we do to support patients’ mental health during trial participation? Prioritising open and regular dialogue with participants, with particular focus on their health beyond just the physical aspects, may help to identify situations where their mental health is being affected. This may require using mental health assessments, including re-assessment at regular touchpoints. Helping patients to understand what is happening during the course of the clinical trial, as well as what will be happening next, is also vital to ensuring they stay informed and feel in control.
And perhaps key is following up with patients, even after trial end. But that is a whole article in and of itself, and so we’ll save that for another day!
References:
- Robberz AS, et al. Support Care Cancer. 2020;28(4):1799–1807.
- Peng Z, et al. Cancer Med. 2023;12(19):20015–20026.
- The Importance Of Looking After A Patient’s Mental Health During Clinical Trials. MD Group. 2020. Link here. Last accessed May 2024
- Jones RA, et al. Int J Behav Nutr Phys Act. 2021;18:146.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience
Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.
Cuttsy+Cuttsy welcomes three new experts to the team
Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.
The gap between hype and reality, what patients really say about weight loss drugs
Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.
Why patient-centricity depends on site-centricity in clinical trials
Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.
From cloudy to clear: visualising complex data privacy information
Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.
UK clinical trial regs are changing — here’s what’s happening
Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.
The invisible influence on trial retention: why caregivers must be part of the plan
Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.
Where it all began: why we wrote ‘The Site Factor’
Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.
From text to context: Helping patients see side effects clearly
Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.
Why patient engagement must come first in rare disease trials
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.